PODCAST: Progress on premature babies, March of Dimes report
In an exclusive interview with Charles J. Lockwood, MD, MHCM, senior vice president, University of South Florida (USF) Health, and dean, USF Health Morsani College of Medicine, Tampa, we asked what steps physicians can take to impact the sobering statistic of 1 in 9 US infants still being born at 37 or fewer weeks.
In Contemporary Pediatrics’ exclusive interview with Charles J. Lockwood, MD, MHCM, senior vice president, University of South Florida (USF) Health, and dean, USF Health Morsani College of Medicine, Tampa, we asked what steps physicians can take to impact the sobering statistic of 1 in 9 US infants still being born at 37 or fewer weeks’ gestation. Hear what he believes were the factors that led to the improvement and what strategies he thinks can be implemented in those states still receiving poor or failing grades.
Dupilumab (Dupixent) becomes first FDA-approved drug for adolescent CRSwNP
September 13th 2024The landmark indication is supported by a couple of pivotal trials assessing dupilumab for patients with chronic rhinosinusitis with nasal polyps, as well as a pediatric severe asthma trial assessing the biologic.
